Outcomes of peroral endoscopic myotomy in patients with achalasia and prior bariatric surgery: A multicenter experience.


Journal

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
ISSN: 1442-2050
Titre abrégé: Dis Esophagus
Pays: United States
ID NLM: 8809160

Informations de publication

Date de publication:
24 Dec 2021
Historique:
received: 14 03 2021
revised: 02 06 2021
accepted: 12 06 2021
pubmed: 30 6 2021
medline: 28 12 2021
entrez: 29 6 2021
Statut: ppublish

Résumé

Peroral endoscopic myotomy (POEM) in patients with achalasia who are status post bariatric surgery may be technically challenging due to postsurgical scarring and altered anatomy. The aim of the study was to assess the efficacy and safety of POEM for achalasia in patients with prior bariatric surgery. A review of prospectively maintained databases at three tertiary referral centers from January 2015 to January 2021 was performed. The primary outcome of interest was clinical success, defined as a post-treatment Eckardt score ≤ 3 or improvement in Eckardt score by ≥ 1 when the baseline score was <3, and improvement of symptoms. Secondary outcomes were adverse event rates and symptom recurrence. Sixteen patients status post Roux-en-Y gastric bypass (n = 14) and sleeve gastrectomy (n = 2) met inclusion criteria. Indications for POEM were achalasia type I (n = 2), type II (n = 9), and type III (n = 5). POEM was performed either by anterior or posterior approach. The pre-POEM mean integrated relaxation pressure was 26.2 ± 7.6 mm Hg. The mean total myotomy length was 10.2 ± 2.7 cm. The mean length of hospitalization was 1.4 ± 0.7 days. Pre- and postprocedure Eckardt scores were 6.1 ± 2.1 and 1.7 ± 1.8, respectively. The overall clinical success rate was 93.8% (15/16) with mean follow-up duration of 15.5 months. One patient had esophageal leak on postprocedure esophagram and managed endoscopically. Dysphagia recurred in two patients, which was successfully managed with pneumatic dilation with or without botulinum toxin injection. POEM appears to be safe and effective in the management of patients with achalasia who have undergone prior bariatric surgery.

Identifiants

pubmed: 34184036
pii: 6310824
doi: 10.1093/dote/doab044
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

S Bomman (S)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

J S Klair (JS)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

M Ashat (M)

Division of Gastroenterology and Hepatology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

R El Abiad (R)

Division of Gastroenterology and Hepatology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

H Gerke (H)

Division of Gastroenterology and Hepatology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

J Keech (J)

Division of Thoracic Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

K Parekh (K)

Division of Bariatric Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

P Nau (P)

Division of Thoracic Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Y Hanada (Y)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

L M Wong Kee Song (LM)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

R Kozarek (R)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

S Irani (S)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

D Low (D)

Division of Thoracic Surgery, Virginia Mason Medical Center, Seattle, WA, USA.

A Ross (A)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

R Krishnamoorthi (R)

Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH